⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

June 5, 2024Deleted JournalOpen Access

Oncolytic vaccinia virus harboring CLEC2A gene enhances viral replication and antitumor efficacy

Gao Chun-Qing Ying Qi Yufeng Qiu Ningbo Ren Kan Chen Yanrong Zhou Ting Ye Gongchu Li

View Full Paper

Ask AI

Bookmark

Share

Abstract

In the field of innovative cancer treatment strategies, oncolytic vaccinia virus (VV)es have gained traction as promising vectors. In the current study, we inserted the human

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Chun-Qing et al. (2024) studied this question.

synapsesocial.com/papers/68e65fa0b6db6435875ee08e https://doi.org/10.1016/j.omton.2024.200823

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Recent progress in combination therapy of oncolytic vaccinia virus2024 · 35 citations
2Abstract C015: Bioengineering and characterization of an oncolytic Vaccinia virus platform for tumor localized lentiviral vector productionOriginal Research · 2026
3Treatment with oncolytic vaccinia virus infects tumor-infiltrating regulatory and exhausted T cells2024 · 7 citations
4The Use of Oncolytic Vaccinia Viruses in the Treatment of Cancer: A New Role for an Old Ally?Review · 2005 · 56 citations
5Associated antitumor effects of oncoytic vaccinia virus expressing a tethered IL-12/IL-2 fusion cytokine.Original Research · 2026

More related papers

Synergistic Oncolytic Effect of HSVtk- and IL-15Rα-Armed Vaccinia Viruses Inducing Systemic Antitumor Immunity2026
Oncolytic vaccinia virus encoding constitutively active EPAC remodels the tumor microenvironment to enhance therapeutic efficacy with chemotherapy and surgery2026
Immunotherapy (Vaccination) of Cancers with immune cells infecetd with Oncolytic Vaccinia Virus (VV)2026